Develop Strategies Based On The Latest Product, Brand, Expansion And Research With Germany Drug Delivery Devices Investment Report

October 7, 2008 12:21 PM EDT

DUBLIN, Ireland--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/2f74ba/germany_drug_deliv) has announced the addition of the "Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering.

Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Germany drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Germany

Scope

- The report provides drug delivery devices information broken down into detailed categories and segments in Germany.

    - Total revenues, products sold, end users, and average pricing.

    - Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

    - Customer, hospitals and physicians data.

    Key Topics Covered:

    1 Contents

    2 Introduction

    3 Healthcare Sector Review

    4 Drug Delivery Devices in Germany

    5 Inhalation Systems in Germany

    6 Infusion Systems in Germany

    7 Needle Free Injections in Germany

    8 AstraZeneca PLC Company Profile

    9 3M Company Profile

    10 GlaxoSmithKline plc Company Profile

    11 Baxter International Company Profile

    12 Novartis AG Company Profile

    13 Regulation System

    14 Pricing and Reimbursement

    15 Distribution Structure

    16 Appendix

    Executive Summary

    Companies Mentioned:

    AstraZeneca PLC

    3M Company

    GlaxoSmithKline plc

    Baxter International

    Novartis AG

    For more information visit
http://www.researchandmarkets.com/research/2f74ba/germany_drug_deliv

Source: Global Markets Direct

Source: Research and Markets Ltd.

Stocks Mentioned


Add Your Comment